Celltrion previously completed phase I clinical trials with a nebulised formulation of Regkirona (regdanvimab, CT-P59), a monoclonal antibody treatment for COVID-19 Celltrion anticipates CT-P63 to maintain strong neutralising ability against Omicron b
Unique service helps employers and employees with a healthier, safer return to the workplace TORONTO--(BUSINESS WIRE)--LifeWorks, a world leader in providing in-person and digital solutions that support the total wellbeing of individuals, now offers on-s
This closing represents High Tide’s largest acquisition to-date, 6th global e-commerce related acquisition in 2021, and 3rd in the CBD space, taking international revenue from approximately CAD$10.6 million at October 31, 2020 to approximately CAD$80
SASKATOON, Saskatchewan & LONDON--(BUSINESS WIRE)--Gensource Potash Corporation (“Gensource” or the “Company”) (AIM/TSXV:GSP), a fertilizer development company focused on sustainable potash production, announces that it has released its Financial
Building a Patient-Centered Community by Generating Meaningful Data, Enhancing Collaborations, and Accelerating Outcomes CALGARY, Alberta--(BUSINESS WIRE)--#Mito--Lumiio is proud to announce the launch of MitoCanada's mitochondrial disease patient regist
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO--(BUSINESS WIRE)--$HMPS #CBD--Hempsana Holdings Ltd. (the “Com
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has completed a significant shipment of one million QuickS
VICTORIA, British Columbia--(BUSINESS WIRE)--$IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) is presenting at the Benchmark Company’s Discovery One-on-One Virtual Video Investor Confere
TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (FSE: 3XI), a leading biotech company in fast-acting psychedelics is pleased to announce the successful design of an oromucosal solid pharmaceutical form obt
- Wednesday, December 8th – 11:00 a.m. ET - MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nuvo Pharmaceuticals® Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversi
Game Changers is the first report to compile Canada’s extensive activity in alternative protein development in one place.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.